12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Company News  |  Deals

Phosphagenics, Nippon Zoki Pharmaceuticals Co. Ltd. deal

Following a March 2012 evaluation deal, the companies partnered to develop Phosphagenics' topical TPM/diclofenac to treat acute and chronic pain in the U.S. The companies partnered last year to allow Nippon...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >